ARTICLE | Company News
Roche (SIX:ROG; OTCQX:RHHBY) is following the trend of suspending price increases in the U.S. for this year after President Donald Trump and HHS Secretary Alex Azar publicly demanded changes in drug pricing.
Roche said in a statement that it informed HHS on the decision to halt price increases on July 11. Two other European pharmas also said they plan to abstain from price increases for the year...